Palo Verde Hematology Oncology is a clinical research site located in Glendale, Arizona, United States 85304.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
Palo Verde Hematology Oncology has participated in 18 clinical trials with 7 currently active.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Triple Negative Breast Cancer, Polycythemia Vera.
Sponsors: Xencor, Inc., Gilead Sciences, Protagonist Therapeutics, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Arizona · View every site in Glendale
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Palo Verde Hematology Oncology has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Palo Verde Hematology Oncology has 18 clinical trials on record, with 7 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Triple Negative Breast Cancer, Polycythemia Vera.
Palo Verde Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.